PRESS RELEASE published on 01/17/2024 at 15:00, 2 years 8 months ago Xenetic Biosciences, Inc. Enters into Research Agreement with the University of Virginia for the Advancement of its DNase-Based Oncology Platform Xenetic Biosciences, Inc. has entered into a Research Funding Agreement and a Material Transfer Agreement with the University of Virginia to advance the development of its systemic DNase program, targeting neutrophil extracellular traps involved in cancer progression. The company believes that the data generated by its research and development collaborations are crucial for unlocking the potential of its DNase technology and driving a clinical path for its lead solid tumor indications. The agreement with UVA provides a significant addition to Xenetic's development capabilities and resources, accelerating development timelines. Dr. Allan Tsung, an internationally recognized surgical oncologist and scientist, will oversee the research conducted under the agreement. Xenetic is working towards its planned first-in-human study to evaluate DNase combined with immune checkpoint inhibitors or chemotherapy. For more information, visit Xenetic Biosciences' website at www.xeneticbio.com. Xenetic Biosciences DNase Program Neutrophil Extracellular Traps Cancer Progression University Of Virginia
PRESS RELEASE published on 11/10/2023 at 14:35, 2 years 10 months ago Xenetic Biosciences, Inc. Reports Third Quarter 2023 Financial Results
PRESS RELEASE published on 10/11/2023 at 15:05, 2 years 11 months ago Xenetic Biosciences, Inc. to Participate at the Virtual Investor Ask the CEO Conference
Published on 09/17/2026 at 15:55, 2 hours 32 minutes ago Empress Announces Agreement to Acquire Tongon Gold Stream and Secures Debt Financing
Published on 09/17/2026 at 15:25, 3 hours 2 minutes ago AIAI Holdings' Constellation Network Launches Dôr Patient Journey with Proactive MD(R), Expanding Transformational AI In Healthcare
Published on 09/17/2026 at 15:00, 3 hours 27 minutes ago Norsemont Hits 41 Meters of 4.59 g/t Gold as Phase 3 Drilling Continues to Expand the Choquelimpie System
Published on 09/17/2026 at 15:00, 3 hours 27 minutes ago ECC Ventures 4 Announces Termination of Agreement With Cambria Gold Mines Inc.
Published on 09/17/2026 at 14:50, 3 hours 37 minutes ago Caldwell Strengthens Human Resources Practice with Addition of Ali Palmer as Partner
Published on 09/17/2026 at 18:10, 16 minutes ago A robust adjusted EBIT margin of 18.8%, driven by solid organic revenue growth of 7.4%
Published on 09/17/2026 at 17:46, 40 minutes ago RBI categorically denies the allegations of short-seller report
Published on 09/17/2026 at 17:45, 41 minutes ago Huawei Pioneers a New Computing Architecture for the AI Era: Making One Million Processors Work as One Computer
Published on 09/17/2026 at 17:45, 41 minutes ago Press release: Information on Leonteq's shareholder base
Published on 09/17/2026 at 17:30, 56 minutes ago AML RightSource Recognized with CobraSight Award for Digital Asset Compliance Expertise
Published on 09/17/2026 at 17:40, 47 minutes ago Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany
Published on 09/17/2026 at 17:40, 47 minutes ago Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany
